Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.21% dropped 0.24% to $171.90 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.36% falling 0.13% to 4,514.07 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.43% falling 0.20% to 35,031.07. This was the stock's second consecutive day of losses. Johnson & Johnson closed $8.02 short of its 52-week high ($179.92), which the company reached on August 20th.
Despite its losses, the stock outperformed some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -0.52% fell 0.71% to $390.93, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.69% fell 0.82% to $75.36, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.72% fell 0.51% to $46.51.true Trading volume (4.6 M) remained 977,513 below its 50-day average volume of 5.6 M.